219 related articles for article (PubMed ID: 32866583)
1. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
2. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
[No Abstract] [Full Text] [Related]
3. Novel Azoles as Antiparasitic Remedies against Brain-Eating Amoebae.
Anwar A; Mungroo MR; Khan S; Fatima I; Rafique R; Kanwal ; Khan KM; Siddiqui R; Khan NA
Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32316387
[No Abstract] [Full Text] [Related]
4. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
5. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
[TBL] [Abstract][Full Text] [Related]
6. Future Priorities in Tackling Infections Due to Brain-Eating Amoebae.
Khan NA; Anwar A; Siddiqui R
ACS Chem Neurosci; 2017 Nov; 8(11):2355. PubMed ID: 28933530
[TBL] [Abstract][Full Text] [Related]
7. Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
Akbar N; Hussain K; Khalid M; Siddiqui R; Shah MR; Khan NA
J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37024269
[TBL] [Abstract][Full Text] [Related]
8. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Siddiqui R
ACS Chem Neurosci; 2017 Dec; 8(12):2626-2630. PubMed ID: 29206032
[TBL] [Abstract][Full Text] [Related]
9. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
10. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic free-living amoebae: epidemiology and clinical review.
Trabelsi H; Dendana F; Sellami A; Sellami H; Cheikhrouhou F; Neji S; Makni F; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):399-405. PubMed ID: 22520593
[TBL] [Abstract][Full Text] [Related]
12. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
Peroutka-Bigus N; Bellaire BH
J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
[TBL] [Abstract][Full Text] [Related]
13. Investigational drug available directly from CDC for the treatment of infections with free-living amebae.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):666. PubMed ID: 23965830
[TBL] [Abstract][Full Text] [Related]
14. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
Baig AM
Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
[TBL] [Abstract][Full Text] [Related]
15. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
[TBL] [Abstract][Full Text] [Related]
16. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
17. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
Baig AM
Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Glucokinases from Pathogenic Free-Living Amoebae.
Milanes JE; Suryadi J; Monaghan NP; Harding EM; Morris CS; Rozema SD; Khalifa MM; Golden JE; Phan IQ; Zigweid R; Abendroth J; Rice CA; McCord HT; Wilson S; Fenwick MK; Morris JC
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0237321. PubMed ID: 35604214
[TBL] [Abstract][Full Text] [Related]
19. Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
Siddiqui R; Mungroo MR; Anuar TS; Alharbi AM; Alfahemi H; Elmoselhi AB; Khan NA
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740156
[TBL] [Abstract][Full Text] [Related]
20. Detection of serum antibodies in children and adolescents against Balamuthia mandrillaris, Naegleria fowleri and Acanthamoeba T4.
Lares-Jiménez LF; Borquez-Román MA; Alfaro-Sifuentes R; Meza-Montenegro MM; Casillas-Hernández R; Lares-Villa F
Exp Parasitol; 2018 Jun; 189():28-33. PubMed ID: 29673623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
